Know Cancer

or
forgot password


Phase 2
1 Year
21 Years
Not Enrolling
Both
Neoplasms

Thank you

Trial Information

Inclusion Criteria


- children 1-21 years of age

- confirmed diagnosis of measurable solid tumor, including brain tumor, which has
progressed on or after standard therapy, or for which no effective standard therapy
is known

- at least 4 weeks since last dose of immunotherapy, radiotherapy, or chemotherapy

- no more than 3 prior chemotherapies

- no symptomatic brain metastases

Type of Study:

Interventional

Study Design:

Allocation: Randomized, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Outcome Measure:

estimate response rate

Principal Investigator

Bristol-Myers Squibb

Investigator Role:

Study Director

Investigator Affiliation:

Bristol-Myers Squibb

Authority:

United States: Food and Drug Administration

Study ID:

CA124-002

NCT ID:

NCT00057473

Start Date:

February 2003

Completion Date:

February 2004

Related Keywords:

  • Neoplasms
  • unspecified childhood solid tumor, protocol specific
  • Neoplasms

Name

Location

Local InstitutionFort Lauderdale, Florida  
Local InstitutionAustin, Texas